| Code | 8860A | ||||||||||
| MA number | 50/0057/14-S | ||||||||||
| Product Form: | tbl 100x25 mg (obal PP) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | MEDOCHEMIE Ltd., Cyprus | ||||||||||
| Therapeutic Class: | 50 - DIURETICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 60 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 30.01.2014 |
| Pediatric posology: | Yes |
| SPC: |
SPC_MEDOSPIR 25 mg_08.2025.pdf
|
| PIL: |
PIL_MEDOSPIR 25 mg_08.2025.pdf
|
| Safety feature | Yes |
| Data update: | 23.08.2018 |
